BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19930741)

  • 21. Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer.
    Vulto JC; Lybeert ML; Louwman MW; Poortmans PM; Coebergh JW
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):464-71. PubMed ID: 19289268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80.
    Rao VS; Jameel JK; Mahapatra TK; McManus PL; Fox JN; Drew PJ
    Breast J; 2007; 13(4):368-73. PubMed ID: 17593041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three men with breast cancer].
    Bergs EA; Tanis PJ; Steller EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer recurrences in elderly patients after lumpectomy.
    Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND
    Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing practice in systemic breast cancer adjuvant treatment in a well-defined French population.
    Chaplain G; Coudert B; Milan C; Altwegg T; Esteve J
    Bull Cancer; 1999 Oct; 86(10):855-60. PubMed ID: 10572236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial].
    Delozier T; Switsers O; Génot JY; Ollivier JM; Héry M; Namer M; Frenay M; Kerbrat P; Julien JP; Naja A; Janvier M; Macé-Lesec'h J
    Bull Cancer; 1997 Jan; 84(1):25-30. PubMed ID: 9180855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center.
    Rosenkranz KM; Bedrosian I; Feng L; Hunt KK; Hartman K; Lucci A; Meric-Bernstam F; Kuerer HM; Singletary ES; Hwang R; Feig B; Ross M; Ames F; Babiera GV
    Am J Surg; 2006 Oct; 192(4):541-4. PubMed ID: 16978971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients.
    DeMichele A; Putt M; Zhang Y; Glick JH; Norman S
    Cancer; 2003 May; 97(9):2150-9. PubMed ID: 12712466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undertreatment strongly decreases prognosis of breast cancer in elderly women.
    Bouchardy C; Rapiti E; Fioretta G; Laissue P; Neyroud-Caspar I; Schäfer P; Kurtz J; Sappino AP; Vlastos G
    J Clin Oncol; 2003 Oct; 21(19):3580-7. PubMed ID: 12913099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.
    Span PN; Tjan-Heijnen VC; Manders P; Beex LV; Sweep CG
    Oncogene; 2003 Jul; 22(31):4898-904. PubMed ID: 12894232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of radiation after breast conserving surgery (BCS) for DCIS and early invasive breast cancer at Charleston Area Medical Center (CAMC). A study of compliance with National Comprehensive Cancer Network (NCCN) guidelines.
    Dean CT; Jubelirer SJ; Plants BA; Welch CA
    W V Med J; 2009 Oct; 105 Spec No():34-8; quiz 39. PubMed ID: 19999263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM).
    Jara Sánchez C; Ruiz A; Martín M; Antón A; Munárriz B; Plazaola A; Schneider J; Martínez del Prado P; Alba E; Fernández-Aramburo A
    Breast Cancer Res Treat; 2007 Jan; 101(2):215-23. PubMed ID: 16823507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of elderly patients with breast cancer: the time for surgery.
    Rai S; Stotter A
    ANZ J Surg; 2005 Oct; 75(10):863-5. PubMed ID: 16176226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Locally advanced breast cancer in elderly patients: treatment standardised or tailored to individual needs?].
    Sanguinetti A; Ragusa M; De Falco M; Sperlongano P; Calzolari F; Parmeggiani D; Misso C; Piatto A; Parmeggiani U; Avenia N
    Chir Ital; 2007; 59(6):829-33. PubMed ID: 18360988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant systemic therapy for male breast carcinoma.
    Giordano SH; Perkins GH; Broglio K; Garcia SG; Middleton LP; Buzdar AU; Hortobagyi GN
    Cancer; 2005 Dec; 104(11):2359-64. PubMed ID: 16270318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Compliance with the breast cancer guidelines in the region of the Comprehensive Cancer Centre South, 20031/'04].
    van den Hurk CJ; van de Poll-Franse LV; Nolthenius-Puylaert MC; Roukema JA; van der Sangen MJ; Nieuwenhuijzen GA; van den Eijnden-van Raaij AJ; Coebergh JW
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):963-8. PubMed ID: 17225737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
    Rayson D; Saint-Jacques N; Younis T; Meadows J; Dewar R
    CMAJ; 2007 Jan; 176(3):327-32. PubMed ID: 17261829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.